Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media

被引:16
|
作者
Bogaert, D
Veenhoven, RH
Sluijter, M
Wannet, WJW
Rijkers, GT
Mitchell, TJ
Clarke, SC
Goessens, WHF
Schilder, AG
Sanders, EAM
de Groot, R
Hermans, PWM
机构
[1] Erasmus MC Sophia Rotterdam, Pediat Lab, Dept Pediat, NL-3015 GE Rotterdam, Netherlands
[2] Erasmus MC, Dept Med Microbiol & Infect Dis, NL-3015 GE Rotterdam, Netherlands
[3] Spaarne Hosp, Dept Pediat, Haarlem, Netherlands
[4] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands
[5] Univ Utrecht, Med Ctr, Wilhelmina Childrens Hosp, Dept Immunol, Utrecht, Netherlands
[6] Univ Utrecht, Med Ctr, Wilhelmina Childrens Hosp, Dept Otorhinolaryngol, Utrecht, Netherlands
[7] Univ Glasgow, Div Infect & Immun, IBLS, Glasgow G12 8QQ, Lanark, Scotland
[8] Stobhill Gen Hosp, Div Scottish Meningococcus, Glasgow G21 3UW, Lanark, Scotland
[9] Stobhill Gen Hosp, Pneumococcus Reference Lab, Glasgow G21 3UW, Lanark, Scotland
关键词
D O I
10.1128/JCM.43.1.74-83.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A randomized double-blind trial with a 7-valent pneumococcal conjugate vaccine was conducted in The Netherlands among 383 children, aged 1 to 7 years, with a history of recurrent acute otitis media. No effect of vaccination on the pneumococcal colonization rate was found. However, a shift in serotype distribution was clearly observed (R. Veenhoven et al., Lancet 361:2189-2195, 2003). We investigated the molecular epidemiology of 921 pneumococcal isolates retrieved from both the pneumococcal vaccine (PV) and control vaccine (CV) groups during the vaccination study. Within individuals a high turnover rate of pneumococcal restriction fragment end labeling genotypes, which was unaffected by vaccination, was observed. Comparison of the genetic structures before and after completion of the vaccination scheme revealed that, despite a shift in serotypes, there was clustering of 70% of the pneumococcal populations. The remaining isolates (30%) were equally observed in the PV and CV groups. In addition, the degree of genetic clustering was unaffected by vaccination. However, within the population genetic structure, nonvaccine serotype clusters with the serotypes 11, 15, and 23B became predominant over vaccine-type clusters after vaccination. Finally, overall pneumococcal resistance was low (14%), and, albeit not significant, a reduction in pneumococcal resistance as a result of pneumococcal vaccination was observed. Molecular surveillance of colonization in Dutch children shows no effect of pneumococcal conjugate vaccination on the degree of genetic clustering and the genetic structure of the pneumococcal population. However, within the genetic pneumococcal population structure, a clear shift toward nonvaccine serotype clusters was observed.
引用
收藏
页码:74 / 83
页数:10
相关论文
共 50 条
  • [1] Pneumococcal conjugate vaccination in children with recurrent acute otitis media: A therapeutic alternative?
    van Kempen, MJP
    Vermeiren, JS
    Vaneechoutte, M
    Claeys, G
    Veenhoven, RH
    Rijkers, GT
    Sanders, EAM
    Dhooge, IJ
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2006, 70 (02) : 275 - 285
  • [2] Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media
    Veenhoven, RH
    Bogaert, D
    Schilder, AGM
    Rijkers, GT
    Uiterwaal, CSPM
    Kiezebrink, HH
    van Kempen, MJP
    Dhooge, IJ
    Bruin, J
    Ijzerman, EPF
    de Groot, R
    Kuis, W
    Hermans, PWM
    Sanders, EAM
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (07) : 911 - 919
  • [3] Pneumococcal conjugate vaccination does not induce a persisting mucosal IgA response in children with recurrent acute otitis media
    Bogaert, D
    Veenhoven, RH
    Ramdin, R
    Luijendijk, IHT
    Rijkers, GT
    Sanders, EAM
    de Groot, R
    Hermans, PWM
    VACCINE, 2005, 23 (20) : 2607 - 2613
  • [4] Pneumococcal conjugate vaccination for prevention of acute otitis media
    Philip Fireman
    Current Allergy and Asthma Reports, 2001, 1 (4) : 351 - 352
  • [5] Cost Effectiveness of Pneumococcal Conjugate Vaccination against Acute Otitis Media in Children
    Boonacker, Chantal W. B.
    Broos, Pieter H.
    Sanders, Elisabeth A. M.
    Schilder, Anne G. M.
    Rovers, Maroeska M.
    PHARMACOECONOMICS, 2011, 29 (03) : 199 - 211
  • [6] Effect of conjugate pneumococcal vaccine on recurrent acute otitis media
    Esposito, S
    Principi, N
    LANCET, 2003, 362 (9389): : 1080 - 1081
  • [7] Pneumococcal conjugate vaccine increased nasopharyngeal bacterial colonization in children with acute otitis media
    Revai, K
    McCormick, DP
    Patel, J
    Grady, J
    Saeed, K
    Chonmaitree, T
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (01) : S298 - S298
  • [8] Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era
    Pichichero, Michael E.
    Casey, Janet R.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (10) : S12 - S16
  • [9] Pneumococcal vaccination for acute otitis media
    Arguedas, A
    Soley, C
    LANCET, 2006, 367 (9526): : 1897 - 1898
  • [10] Pneumococcal conjugate vaccines for preventing acute otitis media in children
    de Sevaux, Joline L. H.
    Venekamp, Roderick P.
    Lutje, Vittoria
    Hak, Eelko
    Schilder, Anne G. M.
    Sanders, Elisabeth A. M.
    Damoiseaux, Roger A. M. J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (11):